Gain Therapeutics appoints Gianluca Fuggetta as Principal Accounting Officer

Gain Therapeutics, Inc.

Gianluca Fuggetta, Finance Director Corporate Reporting since July 2022, appointed Principal Accounting Officer effective Dec 12, 2022.
Prior to Gain Therapeutics, Fuggetta spent nearly 9 years at PricewaterhouseCoopers, most recently as Assurance Manager.
CFO Salvatore Calabrese, who previously served as both Principal Financial and Accounting Officer, will continue as Principal Financial Officer.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Salvatore Calabrese

Principal Accounting Officer

GANX · Gain Therapeutics, Inc.

Filed: December 16, 2022, 6:59 PM ET

The Company’s Chief Financial Officer, Salvatore Calabrese, who was previously serving as both Principal Financial Officer and Principal Accounting Officer, will continue serving as the Company's Principal Financial Officer.

Appointed

Gianluca Fuggetta

Principal Accounting Officer

GANX · Gain Therapeutics, Inc.

Effective: 2022-12-12
Filed: December 16, 2022, 6:59 PM ET

On December 12, 2022, Gain Therapeutics, Inc. (the " Company ") appointed Gianluca Fuggetta, its Finance Director, Corporate Reporting, as the Company's Principal Accounting Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Salvatore Calabrese changed role as Principal Accounting Officer at Gain Therapeutics, Inc..

Role: Principal Accounting Officer

Exact text from the filing

The Company’s Chief Financial Officer, Salvatore Calabrese, who was previously serving as both Principal Financial Officer and Principal Accounting Officer, will continue serving as the Company's Principal Financial Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Gianluca Fuggetta was appointed as Principal Accounting Officer at Gain Therapeutics, Inc..

Action: appointed
Role: Principal Accounting Officer

Exact text from the filing

On December 12, 2022, Gain Therapeutics, Inc. (the " Company ") appointed Gianluca Fuggetta, its Finance Director, Corporate Reporting, as the Company's Principal Accounting Officer.

View on SEC.gov

Gain Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-127798

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.